Lessons for advanced therapy manufacturing flexibility and productivity

James Miskin joined Oxford Biomedica in 2000. He has more than 17 years experience in the GxP environment. In his current role, he has overall responsibility for Oxford Biomedica’s Quality systems, analytical testing, lentiviral based bioprocessing development and client programmes. He is also a named inventor on several patents in the field. He holds a Bachelor of Science degree and a PhD in Molecular Biology from the University of Leeds and subsequently conducted post-doctoral research at The Pirbright Institute for a number of years. He is an active member of the UK BioIndustry Association Manufacturing Advisory Committee and is the Advanced Therapies work stream lead for The Medicines Manufacturing Industry Partnership (MMIP).